Perhaps the most precious commodity on Capitol Hill is time. This is only exacerbated over the summer, when congressional recesses are common around the Fourth of July and then, again, in August. Therefore, when Congress is in, there is a scramble to address pressing concerns and “must pass” legislative issues.
The dietary supplements segment has just experienced its largest annual growth rate since 1997. Hear from Dr. Pieter Cohen as he shares his insights on how modernization of DSHEA will help improve category compliance and credibility.
Last week, CHPA, the American Herbal Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance sent a letter to Senators Tammy Baldwin (D-Wisc.) and John Hoeven (R-N.D.), the Chair and Ranking Member of the Appropriations Subcommittee that has jurisdiction over FDA funding, highlighting the need for additional resources for the Office of Dietary Supplement Programs at FDA due to the growing dietary supplement market.
CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.
CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.